Home > News > Nanotechnology and Cancer
September 1st, 2004
Nanotechnology and Cancer
Abstract:
"The NCI Alliance for Nanotechnology in Cancer is a national initiative that will enable us to join together all the communities in the public and private sector that provide discovery, innovation and development expertise in nanotechnology applied to cancer. The Alliance is built on a strong foundation of science and scientific accomplishment. Its implementation will be guided by the Cancer Nanotechnology Plan."
Catch the live webcast on September 13, 2004, 1:00 P.M. - 2:30 P.M. EDT.
Speakers include:
- Dr. Vicki Colvin, Executive Director of the Center for Biological
and Environmental Nanotechnology and Associate Professor of Chemistry, Rice
University
- Dr. Janet Woodcock, Director, FDA Center for Drug Evaluation and
Research
- Dr. Andrew von Eschenbach, Director, NCI
- Dr. Samuel Wickline, Director of Cardiology, Washington University
- Dr. Mauro Ferrari, Special Expert to the NCI on Nanotechnology and
Professor of Biomedical Engineering, Ohio State University
"During the webcast, speakers will address nanotechnology and its application
to cancer, safety and ethical issues, and the future of nanotechnology and
cancer."
Source:
NCI Alliance
Bookmark:
Nanomedicine
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024
The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024
The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024